Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

AZN

Astrazeneca plc ADR

May 21 • 02:45PM ET

78.94

Dollar change +1.83
Percentage change 2.37	%

Healthcare • Drug Manufacturers - General • United Kingdom • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	NDX	P/E	38.91	EPS (ttm)	2.03	Insider Own	0.03%	Shs Outstand	3.10B	Perf Week	2.47%
Market Cap	244.75B	Forward P/E	16.85	EPS next Y	4.68	Insider Trans	0.00%	Shs Float	3.10B	Perf Month	12.56%
Income	6.33B	PEG	2.88	EPS next Q	1.01	Inst Own	15.95%	Short Float	0.28%	Perf Quarter	21.28%
Sales	47.61B	P/S	5.14	EPS this Y	12.06%	Inst Trans	-2.07%	Short Ratio	1.57	Perf Half Y	23.09%
Book/sh	12.63	P/B	6.25	EPS next Y	15.17%	ROA	6.36%	Short Interest	8.53M	Perf Year	5.55%
Cash/sh	2.59	P/C	30.51	EPS next 5Y	13.50%	ROE	17.29%	52W Range	60.47 - 77.93	Perf YTD	17.21%
Dividend Est.	1.55 (1.96%)	P/FCF	28.86	EPS past 5Y	17.72%	ROI	9.64%	52W High	1.29%	Beta	0.49
Dividend TTM	1.45 (1.84%)	Quick Ratio	0.70	Sales past 5Y	16.24%	Gross Margin	73.81%	52W Low	30.54%	ATR (14)	0.98
Dividend Ex-Date	Feb 22, 2024	Current Ratio	0.89	EPS Y/Y TTM	34.54%	Oper. Margin	17.50%	RSI (14)	78.35	Volatility	0.87% 1.04%
Employees	89900	Debt/Eq	0.92	Sales Y/Y TTM	8.60%	Profit Margin	13.30%	Recom	1.66	Target Price	83.00
Option/Short	Yes / Yes	LT Debt/Eq	0.75	EPS Q/Q	20.85%	Payout	73.87%	Rel Volume	1.12	Prev Close	77.11
Sales Surprise	7.47%	EPS Surprise	7.80%	Sales Q/Q	16.55%	Earnings	Apr 25 BMO	Avg Volume	5.42M	Price	78.94
SMA20	3.97%	SMA50	11.38%	SMA200	17.11%	Trades		Volume	4,964,702	Change	2.37%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-16-24	Upgrade	Deutsche Bank	Sell → Hold
Feb-08-24	Downgrade	Deutsche Bank	Hold → Sell
Jan-23-24	Initiated	Morgan Stanley	Overweight	$85
Jan-16-24	Resumed	UBS	Sell
Jan-03-24	Downgrade	Jefferies	Buy → Hold	$78.50 → $70
Dec-18-23	Initiated	HSBC Securities	Buy	$78
Sep-25-23	Upgrade	Jefferies	Hold → Buy	$66.50 → $80
Jul-14-23	Initiated	HSBC Securities	Buy
Jul-12-23	Upgrade	UBS	Neutral → Buy
Jul-05-23	Downgrade	Deutsche Bank	Buy → Hold
Apr-11-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-05-23	Initiated	BMO Capital Markets	Outperform	$82
Sep-15-22	Downgrade	Credit Suisse	Outperform → Neutral
Sep-07-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-29-22	Upgrade	Argus	Hold → Buy	$75
Jun-14-22	Downgrade	UBS	Buy → Neutral
Feb-11-22	Upgrade	DZ Bank	Sell → Hold
Dec-07-21	Downgrade	Jefferies	Buy → Hold
Aug-12-21	Resumed	JP Morgan	Overweight
Apr-12-21	Downgrade	Argus	Buy → Hold

Show Previous Ratings

Today 12:32PM	AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030 (Zacks)
12:15PM	European Equities Close Lower in Tuesday Trading; AstraZeneca Targets $80 Billion in Revenue by 2030 (MT Newswires)
10:13AM	AstraZeneca aims increase its annual revenue by 75% in its post-COVID era (Quartz)
09:10AM	Sector Update: Health Care Stocks Steady Premarket Tuesday (MT Newswires)
08:24AM	AstraZeneca sets sights on $80B in revenue by 2030 (BioPharma Dive)
08:13AM	Loading…
08:13AM	AstraZeneca to harness China's 'explosion' of innovation to boost cell therapy R&D (FierceBiotech.com)
08:08AM	Compugen Ltd. (NASDAQ:CGEN) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:00AM	Midday movers: Microsoft, Xpeng rise; Palo Alto, Keysight fall (Investing.com)
07:48AM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:21AM	AstraZeneca Targets $80 Billion Revenue by 2030, Expects to Launch 20 New Medicines (MT Newswires)
04:01AM	AstraZeneca to establish $1.5bn ADC production site in Singapore (Pharmaceutical Technology)
03:51AM	AstraZenecas Revenue Target Signals Pipeline Momentum (The Wall Street Journal)
03:17AM	AstraZeneca Targets $80 Billion Revenue by 2030 Through Pipeline Expansion (The Wall Street Journal)
03:15AM	AstraZeneca shares rise as pharma group unveils 2030 revenue target (Investing.com)
02:14AM	AstraZeneca aims for $80 billion in total revenue by 2030 (Reuters)
02:00AM	Loading…
02:00AM	AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030 (Business Wire)
May-20-24 11:25PM	European stocks fall on Fed rate concerns; AstraZeneca lifts revenue target (Investing.com)
04:38PM	Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population (Benzinga)
04:18PM	Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute (Benzinga)
10:45AM	AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore (Zacks)
06:47AM	Amgen and AstraZeneca's Lung Disease Drug Study Reports Mixed Results (MT Newswires)
05:21AM	AstraZeneca to build $1.5bn ADCs facility in Singapore (Investment Monitor)
04:22AM	Pfizer wins cancer drug patent case against AstraZeneca (Pharmaceutical Technology)
04:11AM	AstraZeneca to Build $1.5 Billion Cancer Therapy Manufacturing Facility in Singapore (MT Newswires)
02:49AM	AstraZeneca Plans $1.5 Billion Manufacturing Facility In Singapore (The Wall Street Journal)
May-19-24 05:17PM	New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease (Business Wire)
May-18-24 08:06AM	Flora Growth Corp. (NASDAQ:FLGC) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-17-24 04:12PM	Google DeepMind CEO: 'This Is the Next $100 Billion AI Business' (InvestorPlace)
08:10AM	AIM ImmunoTech Inc. (AMEX:AIM) Q1 2024 Earnings Call Transcript (Insider Monkey)
04:42AM	AstraZenecas Phase III Covid-19 antibody trial meets primary endpoints (Clinical Trials Arena)
01:34PM	Loading…
May-16-24 01:34PM	AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity, Data Shows (Benzinga)
01:12PM	AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial (MT Newswires)
10:51AM	Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game (Benzinga)
07:17AM	AstraZeneca prepares fresh COVID push to regulators after antibody's phase 3 success (FierceBiotech.com)
07:15AM	7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs (InvestorPlace)
06:22AM	AstraZeneca selects new heart failure target with BenevolentAI (Pharmaceutical Technology)
06:10AM	7 Blue-Chip Stocks to Protect Your Wealth as the Economy Slows (InvestorPlace)
May-13-24 11:00PM	PRESS DIGEST-British Business - May 14 (Reuters)
02:07PM	UK pharma giants pledge £430m investment in France after Macron charm offensive (The Telegraph)
01:35PM	Update: AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study (MT Newswires)
12:43PM	AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study (MT Newswires)
12:22PM	SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:44AM	Invivyd, Inc. (NASDAQ:IVVD) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:30AM	France Secures $16 Billion From Microsoft, Amazon and Others at Foreign Investment Summit (The Wall Street Journal)
07:37AM	Pfizer, AstraZeneca, Morgan Stanley Pledge Investments, Jobs to France (MT Newswires)
12:45AM	UPDATE 3-'Choose France' investment push bags record $16 billion in pledges (Reuters)
May-12-24 08:28AM	Pfizer and AstraZeneca announce new investments of nearly $1 billion in France (Reuters)
08:25AM	UPDATE 1-Pfizer and AstraZeneca announce new investments of nearly $1 billion in France (Reuters)
08:20AM	Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead (Motley Fool)
May-10-24 09:45AM	Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term (Zacks)
09:30AM	Catalyst's New CEO Has Big Ideas For The Small Biotech (Investor's Business Daily)
06:30AM	3 Biotech Stocks to Sell in May Before They Crash & Burn (InvestorPlace)
May-09-24 03:48PM	Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript (Insider Monkey)
12:31PM	Personalis, Inc. (NASDAQ:PSNL) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:26AM	Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb (PR Newswire)
May-08-24 04:28PM	Update: AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents (MT Newswires)
04:08PM	AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents (MT Newswires)
03:15PM	Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:07PM	AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement (MT Newswires)
01:30PM	AstraZenca is pulling its COVID vaccine (Quartz)
01:06PM	Every household should be forced to have a smart meter, says British Gas boss (The Telegraph)
11:47AM	AstraZeneca withdraws Covid-19 vaccine, citing low demand (CNN Business)
09:04AM	AstraZeneca to Reportedly Withdraw COVID-19 Vaccine Amid Cooling Demand (MT Newswires)
08:30AM	Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024 (GlobeNewswire)
08:12AM	AstraZeneca withdraws COVID-19 vaccine, citing declining demand (BioPharma Dive)
06:02AM	AstraZeneca to withdraw Covid-19 vaccine globally (Pharmaceutical Technology)
06:00AM	7 Stocks to Buy Before the Next 'Great Reset' Begins in 2024 (InvestorPlace)
05:20AM	Q1 2024 Ionis Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
May-07-24 11:12PM	PRESS DIGEST-British Business - May 8 (Reuters)
05:03PM	UPDATE 3-AstraZeneca to withdraw COVID vaccine globally as demand dips (Reuters)
10:15AM	FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:57AM	Q1 2024 FibroGen Inc Earnings Call (Thomson Reuters StreetEvents)
04:31AM	AstraZeneca concludes equity investment in Cellectis (Pharmaceutical Technology)
May-06-24 02:06PM	How the Medical Industry Could Produce the Biggest AI Stock Winners (InvestorPlace)
11:45AM	Why Astrazeneca (AZN) is a Top Dividend Stock for Your Portfolio (Zacks)
07:58AM	AstraZeneca ups stake in Cellectis in latest cell therapy bet (BioPharma Dive)
04:22AM	Cellectis Secures $140 Million Additional Equity Investment From AstraZeneca (MT Newswires)
02:00AM	Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca (GlobeNewswire)
May-04-24 07:38AM	23 Most Profitable Stocks of the Last 12 Months (Insider Monkey)
May-03-24 12:15PM	Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 (PR Newswire)
04:21AM	AstraZeneca reports positive interim data from mantle cell lymphoma trial (Clinical Trials Arena)
02:00AM	Angle PLC Announces New Commercial Agreement with Large Pharma (ACCESSWIRE)
May-02-24 03:29PM	Boston Properties, Inc. (NYSE:BXP) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:02AM	AstraZeneca Says Calquence Combination Improves Progression-Free Survival in Phase 3 Mantle Cell Lymphoma Trial (MT Newswires)
07:00AM	CALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trial (Business Wire)
May-01-24 12:02PM	AstraZeneca admits Covid-19 vaccine may cause blood clots in very rare cases (Pharmaceutical Technology)
07:05AM	AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio (Business Wire)
Apr-30-24 10:40AM	AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-29-24 04:38PM	AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown (Benzinga)
11:22AM	AstraZenecas Fasenra: Approval for asthma may initiate COPD approval (Pharmaceutical Technology)
10:56AM	AIM ImmunoTech Says Safety Evaluation of First Dose Level of Pancreatic Cancer Study Completed (MT Newswires)
10:26AM	AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement (MT Newswires)
07:10AM	AstraZeneca, Daiichi look to broaden Enhertu use again with new study data (BioPharma Dive)
07:00AM	ENHERTU (fam-trastuzumab deruxtecan-nxki) improved PFS in HER2-low and ultralow (Business Wire)
Apr-26-24 05:16AM	Analyst Report: AstraZeneca PLC (Morningstar Research)
Apr-25-24 08:28PM	Analyst Report: AstraZeneca PLC (Morningstar Research) +5.38%
04:01PM	AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge (Investor's Business Daily)
03:49PM	AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain' (Yahoo Finance)
01:51PM	Sector Update: Health Care Stocks Drop in Afternoon Trading (MT Newswires)
01:47PM	AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up (Zacks)

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AZN

Astrazeneca plc ADR

Upgrade your FINVIZ experience